Associations of levels of high-molecular-weight adiponectin, secreted frizzled-related protein 5 and vascular endothelial growth factor-165 with diabetic retinopathy

1 Bene BA, O’Connor S, Mastellos N, Majeed A, Fadahunsi KP, O’Donoghue J. Impact of mobile health applications on self-management in patients with type 2 diabetes mellitus: protocol of a systematic review. BMJ Open. 2019;9(6):e025714. DOI: 10.1136/bmjopen-2018-025714 Search in Google Scholar

2 Li W, Jin L, Cui Y, Nie A, Xie N, Liang G. Bone marrow mesenchymal stem cells-induced exosomal microRNA-486-3p protects against diabetic retinopathy through TLR4/NF-κB axis repression. J Endocrinol Invest. 2021;44(6):1193-207. DOI: 10.1007/s40618-020-01405-3 Search in Google Scholar

3 Louie HH, Shome A, Kuo CY, Rupenthal ID, Green CR, Mugisho OO. Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathy. Exp Eye Res. 2021;202:108384. DOI: 10.1016/j. exer.2020.108384 Search in Google Scholar

4 Yu HS, Hong EH, Shin YU, Koh SH, Cho H. ATP-binding cassette subfamily A-1 (ABCA1) levels are increased in the aqueous humour of proliferative diabetic retinopathy patients. Acta Ophthalmol. 2021;99(3):e442-3. DOI: 10.1111/aos.14550 Search in Google Scholar

5 Horakova D, Stepanek L, Nagelova R, Pastucha D, Azeem K, Kollarova H. Total and high-molecular-weight adiponectin levels and prediction of insulin resistance. Endokrynol Pol. 2018;69:375-80. DOI: 10.5603/EP.a2018.0035 Search in Google Scholar

6 Juuti-Uusitalo K, Nieminen M, Treumer F, Ampuja M, Kallioniemi A, Klettner A, et al. Effects of Cytokine Activation and Oxidative Stress on the Function of the Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells. Invest Ophthalmol Vis Sci. 2015;56(11):6265-74. DOI: 10.1167/iovs.15-17333 Search in Google Scholar

7 Maturi RK, Glassman AR, Josic K, Antoszyk AN, Blodi BA, Jampol LM, et al. Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial. JAMA Ophthalmol. 2021;139(7):701-12. DOI: 10.1001/jamaophthalmol.2021.0606 Search in Google Scholar

8 Xu W, Geng H, Liu X, Wang X, Li R, Lv Q, et al. Wingless-type MMTV integration site family member 5a: a novel biomarker regulated in type 2 diabetes mellitus and diabetic kidney disease. J Diabetes Metab Disord. 2019;18(2):525-32. DOI: 10.1007/s40200-019-00461-8 Search in Google Scholar

9 Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 2012;12(4):346-54. DOI: 10.1007/s11892-012-0283-6 Search in Google Scholar

10 Simó-Servat O, Hernández C, Simó R. Diabetic Retinopathy in the Context of Patients with Diabetes. Ophthalmic Res. 2019;62(4):211-7. DOI: 10.1159/000499541 Search in Google Scholar

11 Saw M, Wong VW, Ho IV, Liew G. New anti-hyperglycaemic agents for type 2 diabetes and their effects on diabetic retinopathy. Eye (Lond). 2019;33(12):1842-51. DOI: 10.1038/s41433-019-0494-z Search in Google Scholar

12 Grzybowski A, Brona P, Lim G, Ruamviboonsuk P, Tan GSW, Abramoff M, et al. Artificial intelligence for diabetic retinopathy screening: a review. Eye. 2020;34:451-60. DOI: 10.1038/s41433-019-0566-0 Search in Google Scholar

13 Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig. 2021;12(8):1322-5. DOI: 10.1111/jdi.13480 Search in Google Scholar

14 Khan SZ, Ajmal N, Shaikh R. Diabetic Retinopathy and Vascular Endothelial Growth Factor Gene Insertion/Deletion Polymorphism. Can J Diabetes. 2020;44(3):287-91. DOI: 10.1016/j.jcjd.2019.08.005 Search in Google Scholar

15 Frank RN. Anti-Vascular Endothelial Growth Factor Injections for Diabetic Retinopathy: Continued Progress, More Questions. Ophthalmology. 2019;126(5):721-2. DOI: 10.1016/j.ophtha.2018.11.011 Search in Google Scholar

16 Kato K, Osawa H, Ochi M, Kusunoki Y, Ebisui O, Ohno K, et al. Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy. Clin Endocrinol. 2008;68(3):442-9. DOI: 10.1111/j.1365-2265.2007.03063.x Search in Google Scholar

17 Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, et al. Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy. JAMA. 2023;329(5):376-85. DOI: 10.1001/jama.2022.25029 Search in Google Scholar

18 Liu LB, Chen XD, Zhou XY, Zhu Q. The Wnt antagonist and secreted frizzled-related protein 5: implications on lipid metabolism, inflammation, and type 2 diabetes mellitus. Biosci Rep. 2018;38(4):BSR20180011. DOI: 10.1042/BSR20180011 Search in Google Scholar

19 Zhu DD, Wang YZ, Zou C, She XP, Zheng Z. The role of uric acid in the pathogenesis of diabetic retinopathy based on Notch pathway. Biochem Biophys Res Commun. 2018;503(2):921-9. DOI: 10.1016/j.bbrc.2018.06.097 Search in Google Scholar

20 Fan J, Shen W, Lee SR, Mathai AE, Zhang R, Xu G, et al. Targeting the Notch and TGF-β signaling pathways to prevent retinal fibrosis in vitro and in vivo. Theranostics. 2020;10(18):7956-73. DOI: 10.7150/thno.45192 Search in Google Scholar